These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15871681)

  • 41. Informed consent: practices and views of investigators in a multinational clinical trial.
    Sabik L; Pace CA; Forster-Gertner HP; Wendler D; Bebchuk JD; Tavel JA; McNay LA; Killen J; Emanuel EJ; Grady C
    IRB; 2005; 27(5):13-8. PubMed ID: 16425476
    [No Abstract]   [Full Text] [Related]  

  • 42. The concept analysis of therapeutic misconception.
    Matutina RE
    Nurse Res; 2010; 17(4):83-90. PubMed ID: 20712237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simple genetics language as source of miscommunication between genetics researchers and potential research participants in informed consent documents.
    Morgenstern J; Hegele RA; Nisker J
    Public Underst Sci; 2015 Aug; 24(6):751-66. PubMed ID: 24751688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical considerations in the design of protocols for somatic gene therapy.
    Ledley FD
    Hum Gene Ther; 1991; 2(1):77-83. PubMed ID: 1863643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality of informed consent in cancer clinical trials: a cross-sectional survey.
    Joffe S; Cook EF; Cleary PD; Clark JW; Weeks JC
    Lancet; 2001 Nov; 358(9295):1772-7. PubMed ID: 11734235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.
    Hum Gene Ther; 2002 Jan; 13(1):3-13. PubMed ID: 11779411
    [No Abstract]   [Full Text] [Related]  

  • 47. The contents and readability of informed consent forms for oncology clinical trials.
    Cheung WY; Pond GR; Heslegrave RJ; Enright K; Potanina L; Siu LL
    Am J Clin Oncol; 2010 Aug; 33(4):387-92. PubMed ID: 19884804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic misconceptions and misestimations in oncology: a clinical trial nurse's guide.
    Scott J
    Clin J Oncol Nurs; 2013 Oct; 17(5):486-9. PubMed ID: 24080047
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
    Vanderpool HY
    Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Informed consent and patient's rights documents: a right, a rite, or a rewrite?
    Hochhauser M
    Ethics Behav; 1999; 9(1):1-20. PubMed ID: 11657485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ethical reflection on human gene therapy in the Chinese context.
    Zhang X
    J Int Bioethique; 2008 Dec; 19(4):95-104, 163. PubMed ID: 19492724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trials.
    Reinert C; Kremmler L; Burock S; Bogdahn U; Wick W; Gleiter CH; Koller M; Hau P
    Eur J Cancer; 2014 Jan; 50(1):150-8. PubMed ID: 24103146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human experimentation. Protecting patient autonomy through informed consent.
    Tuthill KA
    J Leg Med; 1997 Jun; 18(2):221-50. PubMed ID: 9230568
    [No Abstract]   [Full Text] [Related]  

  • 54. Informed consent, confidentiality, and subject rights in clinical trials.
    Smith-Tyler J
    Proc Am Thorac Soc; 2007 May; 4(2):189-93; discussion 193. PubMed ID: 17494730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The therapeutic misconception: problems and solutions.
    Lidz CW; Appelbaum PS
    Med Care; 2002 Sep; 40(9 Suppl):V55-63. PubMed ID: 12226586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer gene therapy: connecting basic research with clinical inquiry.
    Dranoff G
    J Clin Oncol; 1998 Jul; 16(7):2548-56. PubMed ID: 9667277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overcoming language barriers in the informed consent process: regulatory and compliance issues with the use of the "short form".
    Lad PM; Dahl R
    Account Res; 2014; 21(5):315-20. PubMed ID: 24625183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testing an alternate informed consent process.
    Yates BC; Dodendorf D; Lane J; LaFramboise L; Pozehl B; Duncan K; Knodel K
    Nurs Res; 2009; 58(2):135-9. PubMed ID: 19289935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene therapy for colorectal cancer.
    Palmer DH; Chen MJ; Kerr DJ
    Br Med Bull; 2002; 64():201-25. PubMed ID: 12421734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An exploratory study of therapeutic misconception among incarcerated clinical trial participants.
    Christopher PP; Stein MD; Springer SA; Rich JD; Johnson JE; Lidz CW
    AJOB Empir Bioeth; 2016; 7(1):24-30. PubMed ID: 26709382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.